Cross‐sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment von Cutter, Gary, Xin, Haichang, Aban, Inmaculada, Burns, Ted M., Allman, Phillip H., Farzaneh‐Far, Ramin, Duda, Petra W., Kaminski, Henry J.

Volltext

The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice von Burns, Ted M.

Volltext

History of outcome measures for myasthenia gravis von Burns, Ted M.

Volltext

MG-ADL: Still a relevant outcome measure von Muppidi, Srikanth, Wolfe, Gil I., Conaway, Mark, Burns, Ted M.

Volltext

The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events von Hehir, Michael K, Conaway, Mark, Clark, Eric M, Aronzon, Denise B, Kolb, Noah, Kolb, Amanda, Ruzhansky, Katherine, Sadjadi, Reza, De Sousa, Eduardo A, Burns, Ted M

Volltext

International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r von Burns, Ted M., Sadjadi, Reza, Utsugisawa, Kimiaki, Gwathmey, Kelly G., Joshi, Amruta, Jones, Sarah, Bril, Vera, Barnett, Carolina, Guptill, Jeffrey T., Sanders, Donald B., Hobson-Webb, Lisa, Juel, Vern C., Massey, Janice, Gable, Karissa L, Silvestri, Nicholas J., Wolfe, Gil, Cutter, Gary, Nagane, Yuriko, Murai, Hiroyuki, Masuda, Masayuki, Farrugia, Maria Elena, Carmichael, Caroline, Birnbaum, Simone, Hogrel, Jean-Yves, Nafissi, Shahriar, Fatehi, Farzad, Ou, Changyi, Liu, Weibin, Conaway, Mark

Volltext

Construction and Validation of a Novel Disease-Specific Quality of Life Instrument for Patients with Primary Antibody Deficiency Disease (PADQOL -16) von Ballow, Mark, MD, Conaway, Mark R., PhD, Sriaroon, Panida, MD, Rachid, Rima A., MD, Seeborg, Filiz O., MD, Duff, Carla M., CPNP, MSN, CCRP, Bonilla, Francisco A., MD, PhD, Younger, M. Elizabeth M., CRNP, PhD, Shapiro, Ralph, MD, Burns, Ted M., MD

Volltext

Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia gravis von Burns, Ted M., Conaway, Mark R., Cutter, Gary R., Sanders, Donald B.

Volltext

Construction of an efficient evaluative instrument for Myasthenia Gravis: The MG composite von Burns, Ted M., Conaway, Mark R., Cutter, Gary R., Sanders, Donald B.

Volltext

Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis von Sadjadi, Reza, Reilly, Mary M., Shy, Michael E., Pareyson, Davide, Laura, Matilde, Murphy, Sinead, Feely, Shawna M. E., Grider, Tiffany, Bacon, Chelsea, Piscosquito, Giuseppe, Calabrese, Daniela, Burns, Ted M.

Volltext

Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis von Placek, Katerina, Benatar, Michael, Wuu, Joanne, Rampersaud, Evadnie, Hennessy, Laura, Van Deerlin, Vivianna M, Grossman, Murray, Irwin, David J, Elman, Lauren, McCluskey, Leo, Quinn, Colin, Granit, Volkan, Statland, Jeffrey M, Burns, Ted M, Ravits, John, Swenson, Andrea, Katz, Jon, Pioro, Erik P, Jackson, Carlayne, Caress, James, So, Yuen, Maiser, Samuel, Walk, David, Lee, Edward B, Trojanowski, John Q, Cook, Philip, Gee, James, Sha, Jin, Naj, Adam C, Rademakers, Rosa, Chen, Wenan, Wu, Gang, Paul Taylor, J, McMillan, Corey T

Volltext

Myasthenia gravis von Gilhus, Nils Erik, Tzartos, Socrates, Evoli, Amelia, Palace, Jacqueline, Burns, Ted M., Verschuuren, Jan J. G. M.

Volltext

On being sick: Musings about kindness, side effects, and slowing down von Burns, Ted M

Volltext

Estimating and managing fatigue for our patients: Are we measuring up? von Burns, Ted M.

Volltext

Construct and concurrent validation of the MG-QOL15 in the practice setting von Burns, Ted M., Grouse, C.K., Conaway, Mark R., Sanders, Donald B.

Volltext

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis von Howard, James F, Bril, Vera, Burns, Ted M, Mantegazza, Renato, Bilinska, Malgorzata, Szczudlik, Andrzej, Beydoun, Said, Garrido, Francisco Javier Rodriguez De Rivera, Piehl, Fredrik, Rottoli, Mariarosa, Van Damme, Philip, Vu, Tuan, Evoli, Amelia, Freimer, Miriam, Mozaffar, Tahseen, Ward, E Sally, Dreier, Torsten, Ulrichts, Peter, Verschueren, Katrien, Guglietta, Antonio, de Haard, Hans, Leupin, Nicolas, Verschuuren, Jan J.G.M

Volltext

The best of both worlds: Using patient-reported plus physician-scored measures during the evaluation of myasthenia gravis von Burns, Ted M.

Volltext

The MG Composite: A valid and reliable outcome measure for myasthenia gravis von BURNS, Ted M, CONAWAY, Mark, SANDERS, Donald B

Volltext

Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS von Benatar, Michael, Zhang, Lanyu, Wang, Lily, Granit, Volkan, Statland, Jeffrey, Barohn, Richard, Swenson, Andrea, Ravits, John, Jackson, Carlayne, Burns, Ted M., Trivedi, Jaya, Pioro, Erik P., Caress, James, Katz, Jonathan, McCauley, Jacob L., Rademakers, Rosa, Malaspina, Andrea, Ostrow, Lyle W., Wuu, Joanne

Volltext

Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review von Hehir, Michael K, Hobson-Webb, Lisa D, Benatar, Michael, Barnett, Carolina, Silvestri, Nicholas J, Howard, James F, Howard, Diantha, Visser, Amy, Crum, Brian A, Nowak, Richard, Beekman, Rachel, Kumar, Aditya, Ruzhansky, Katherine, Chen, I-Hweii Amy, Pulley, Michael T, LaBoy, Shannon M, Fellman, Melissa A, Greene, Shane M, Pasnoor, Mamatha, Burns, Ted M

Volltext